Nutritional Supplement for Healthy Adults

Overseen By Biofortis Research Clinical Director Biofortis Research Clinical Director

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Shaklee Corporation

Must not be taking: Tobacco, Marijuana, Hormonal therapy, others

Disqualifiers: Diabetes, Hypertension, Cancer, others

Compensation: Varies

Number of Visits: 30

Duration: 8 weeks

34 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.

Who Is on the Research Team?

Erin Barrett, PhD

Principal Investigator

Shaklee Corporation

Are You a Good Fit for This Trial?

Inclusion Criteria

Willing to use personal smart phone with operating system (Android version 12.0 or newer; iOS version 16 or newer)

I can walk and have no injuries or conditions that limit my movement.

My BMI is between 18.5 and 30.

Exclusion Criteria

I have recently started or changed my hormonal contraceptive or therapy.

History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator

Use of any dietary supplements (orally or infused), other than a conventional once daily multi-vitamin

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either the proprietary nutritional supplement or placebo daily

8 weeks

Baseline, Day 30, Day 60

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Placebo Supplement
• Proprietary Nutritional Supplement

How Is the Trial Designed?

Group I: Proprietary nutritional supplement Experimental Treatment 1 Intervention

Participants will take the experimental supplement orally, daily.

Group II: Placebo supplement Placebo Group 1 Intervention

Participants will take the placebo supplement orally, daily.

Who Is Running the Clinical Trial?

Shaklee Corporation

Lead Sponsor

Biofortis Clinical Research, Inc.

Industry Sponsor

Trials

12

Recruited

1,000+

Nlumn LLC

Industry Sponsor